Clinical Trials: Obsessive-Compulsive Disorders

California

Stanford; Stanford University School of Medicine
The purpose of this study is to determine whether memantine (Namenda), in doses up to 20 mg/day, will be effective in treating the obsessive-compulsive disorder (OCD) of adult patients who have not responded to their OCD medication.

Massachusetts

Boston; Psychiatric and Neurodevelopmental Genetics Unit
Family Genetic Study of Gilles de la Tourette Syndrome, Attention Deficit Hyperactivity Disorder, Obsessive Compulsive Disorder and Related Conditions

Charlestown; Massachusetts General Hospital - East
Duloxetine for the Treatment of Obsessive Compulsive Disorder

Charlestown; Massachusetts General Hospital - East
Duloxetine for the Treatment of Obsessive Compulsive Disorder

New York

New York; New York State Psychiatric Institute
Do you have OCD and live in or near NYC?

New York; Mount Sinai Medical Center
Ziprasidone augmentation in serotonin reuptake inhibitor-resistant Obsessive-Compulsive Disorder

New York; The New York State Psychiatric Institute
Do you suffer from Obsessive-Compulsive Disorder and live within commuting distance of New York City?

New York; New York State Psychiatric Institute
Treatment of Obsessive-Compulsive Disorder (OCD) with Transcranial Magnetic Stimulation (TMS)


Back to Clinical Trials by Medical Areas

Research centers
specializing in
this illness area

Additional resources
in this illness area

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listing updated: May 13, 2008 at 3:27:10 PM

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA